Cargando…

Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review

Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hammar, Tora, Hamqvist, Sara, Zetterholm, My, Jokela, Päivi, Ferati, Mexhid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103271/
https://www.ncbi.nlm.nih.gov/pubmed/33805205
http://dx.doi.org/10.3390/pharmacy9020069
_version_ 1783689286301777920
author Hammar, Tora
Hamqvist, Sara
Zetterholm, My
Jokela, Päivi
Ferati, Mexhid
author_facet Hammar, Tora
Hamqvist, Sara
Zetterholm, My
Jokela, Päivi
Ferati, Mexhid
author_sort Hammar, Tora
collection PubMed
description Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert physicians or pharmacists about DDIs are common, and there is an extensive body of research about CDSS for professionals. Information about DDIs is commonly requested by patients, but little is known about providing similar support to patients. The aim of this scoping review was to explore and describe current knowledge about providing digital DDI services for patients. Using a broad search strategy and an established framework for scoping reviews, 19 papers were included. The results show that although some patients want to check for DDIs themselves, there are differences between patients, in terms of demands and ability. There are numerous DDI services available, but the existence of large variations regarding service quality implies potential safety issues. The review includes suggestions about design features but also indicates a substantial knowledge gap highlighting the need for further research about how to best design and provide digital DDI to patients without risking patient safety or having other unintended consequences.
format Online
Article
Text
id pubmed-8103271
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81032712021-05-08 Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review Hammar, Tora Hamqvist, Sara Zetterholm, My Jokela, Päivi Ferati, Mexhid Pharmacy (Basel) Review Drug–drug interactions (DDIs) pose a major problem to patient safety. eHealth solutions have the potential to address this problem and generally improve medication management by providing digital services for health care professionals and patients. Clinical decision support systems (CDSS) to alert physicians or pharmacists about DDIs are common, and there is an extensive body of research about CDSS for professionals. Information about DDIs is commonly requested by patients, but little is known about providing similar support to patients. The aim of this scoping review was to explore and describe current knowledge about providing digital DDI services for patients. Using a broad search strategy and an established framework for scoping reviews, 19 papers were included. The results show that although some patients want to check for DDIs themselves, there are differences between patients, in terms of demands and ability. There are numerous DDI services available, but the existence of large variations regarding service quality implies potential safety issues. The review includes suggestions about design features but also indicates a substantial knowledge gap highlighting the need for further research about how to best design and provide digital DDI to patients without risking patient safety or having other unintended consequences. MDPI 2021-03-24 /pmc/articles/PMC8103271/ /pubmed/33805205 http://dx.doi.org/10.3390/pharmacy9020069 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Review
Hammar, Tora
Hamqvist, Sara
Zetterholm, My
Jokela, Päivi
Ferati, Mexhid
Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title_full Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title_fullStr Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title_full_unstemmed Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title_short Current Knowledge about Providing Drug–Drug Interaction Services for Patients—A Scoping Review
title_sort current knowledge about providing drug–drug interaction services for patients—a scoping review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103271/
https://www.ncbi.nlm.nih.gov/pubmed/33805205
http://dx.doi.org/10.3390/pharmacy9020069
work_keys_str_mv AT hammartora currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview
AT hamqvistsara currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview
AT zetterholmmy currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview
AT jokelapaivi currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview
AT feratimexhid currentknowledgeaboutprovidingdrugdruginteractionservicesforpatientsascopingreview